SCHEMBL7975769

SCHEMBL7975769

CCOC(=O)Cn1c(CC)nc2c(O)cccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
KDM4E B2RXH2 6/20 0.50
HSD17B10 Q99714 4/20 0.50
HPGD P15428 3/20 0.50
TSHR P16473 2/20 0.50
SAE1 Q9UBE0 1/20 0.50
UBA2 Q9UBT2 1/20 0.50
HTT P42858 3/20 0.48
CTNNB1 P35222 1/20 0.46
RAB9A P51151 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
TLR8 Q9NR97 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPT P10636 2/20 0.42
ALOX15 P16050 1/20 0.42
CACNA1B Q00975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7978871 0.78 AKT1 (0.42) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL7981903 0.76 POLB (0.46) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL13318998 0.73 ALDH1A1 (0.52) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL7975692 0.71 TLR8 (0.49) ALDH1A1KDM4EHPGDTSHRHTT
SCHEMBL7981486 0.70 ALDH1A1 (0.56) ALDH1A1KDM4ETSHRRAB9AMAPT
SCHEMBL3164934 0.70 KDM4E (0.46) ALDH1A1KDM4EHSD17B10TSHRHTT
SCHEMBL659788 0.69 GABRA5 (0.43) ALDH1A1KDM4EHSD17B10HTTRAB9A
SCHEMBL3730551 0.69 DCTPP1 (0.57) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL16421959 0.69 KDM4E (0.73) ALDH1A1KDM4EHSD17B10HPGDTSHR
SCHEMBL20037234 0.69 ALDH1A1 (0.61) ALDH1A1KDM4EHSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed